Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009-2020.

Saved in:
Bibliographic Details
Title: Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009-2020.
Authors: Teixeira MX; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil., Reis AMM; Department of Pharmaceutical Products, Federal University of Minas Gerais - UFMG, Belo Horizonte, Brazil., Drummond PLM; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil.; Ezequiel Dias Foundation - Funed, Belo Horizonte, Brazil., Malta JS; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil., Silveira LP; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil.; Hospital das Clínicas da UFMG, Belo Horizonte, Brazil., Menezes de Pádua CA; Department of Social Pharmacy, Federal University of Minas Gerais - UFMG, Avenida Antônio Carlos, 6627 - Pampulha, Belo Horizonte, MG, Brazil. campadua@farmacia.ufmg.br.
Source: Annals of hematology [Ann Hematol] 2024 Dec; Vol. 103 (12), pp. 5881-5889. Date of Electronic Publication: 2024 Mar 09.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0584
DOI:10.1007/s00277-024-05684-1